Bradford team will use GMP capabilities of Aesica; Aesica will use research facilities at University
UK-based contract pharmaceutical manufacturer Aesica has formed a partnership with the Centre for Pharmaceutical Engineering Science at the University of Bradford, which will enable the team at Bradford to use Aesica’s GMP capabilities, while Aesica will benefit from the Centre’s research facilities.
The partnership was formed following a presentation from Dr Riddhi Shukla, business development manager at the Centre for Pharmaceutical Engineering Science to the Aesica Innovation Board and builds on a relationship established in 2009 between both parties.
The Centre offers a number of processing technologies including hot melt extrusion.
Paul Titley, managing director, Formulation Development at Aesica, said: ‘We provide GMP contract manufacturing services to six other universities, but this partnership is particularly important and unique as it is mutually beneficial. While the team at Bradford has development expertise in several key approaches and as such can evaluate the viability of compounds presented by virtual and small pharma organisations, our GMP expertise is crucial to take the compounds into clinical trials.’